about
Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or BClotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or BCanadian hereditary angioedema guideline.Efficacy, safety and tolerability of recombinant factor VIII (REFACTO) in patients with haemophilia A: interim data from a postmarketing surveillance study in Germany and Austria.The potential correlation between patient-reported symptoms and the use of additional haemostatic medication for joint bleeding in haemophilia patients with inhibitors: a post hoc exploratory analysis of recombinant activated factor VII data from thHaemophilia utilization group study - Part Va (HUGS Va): design, methods and baseline data.On demand treatment and home therapy of hereditary angioedema in Germany - the Frankfurt experience.Mixing and administration times of bypassing agents: observations from the Dosing Observational Study in Hemophilia (DOSE).Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in ItalySafety and efficacy of physician-supervised self-managed C1 inhibitor replacement therapy.Therapy for haemophilia: recent advances and goals for the future.Handheld computers and paper diaries for documenting the use of factor concentrates used in haemophilia home therapy: a qualitative study.Central venous access devices in patients with hemophilia.C1-inhibitor concentrate home therapy for hereditary angioedema: a viable, effective treatment option.Barriers and perceived limitations to early treatment of hemophilia.Men with severe hemophilia in the United States: birth cohort analysis of a large national databaseImplantable central venous access device procedures in haemophilia patients without an inhibitor: systematic review of the literature and institutional experience.Causes of Death Among 379 Patients With Hemophilia: A Developing Country's Report.Safety and efficacy of recombinant activated coagulation factor VII in congenital hemophilia with inhibitors in the home treatment setting: A review of clinical studies and registries.Establishing a harmonized haemophilia registry for countries with developing health care systems.Treatment of hemophilia: A qualitative study of mothers' perspectives.Young adults with hemophilia in the U.S.: demographics, comorbidities, and health status.A tortuous route to a capable fatherhood: the experience of being a father to a child with severe haemophilia.Evaluation of Knowledge of Patients with Hemophilia Regarding Their Diseases and Treatment in Iran.Paediatric hereditary angioedema: a survey of UK service provision and patient experience.US Hemophilia Treatment Center population trends 1990-2010: patient diagnoses, demographics, health services utilization.Adherence to treatment in a Western European paediatric population with haemophilia: reliability and validity of the VERITAS-Pro scale.Long-standing prophylactic therapy vs. episodic treatment in young people with severe haemophilia: a comparison of age-matched Danish and Russian patients.Health-related quality of life in haemophilia patients with inhibitors and their caregivers.Optimization of home treatment in haemophilia: effects of transmural support by a haemophilia nurse on adherence and quality of life.Reliability and validity of a novel haemophilia-specific self-efficacy scale.Communicating about haemophilia within the family: the importance of context and of experience.National home infusion teaching guidelines will improve quality of care and patient outcomes in haemophilia treatment centres across the USA.Partnering to change the world for people with haemophilia: 7th Haemophilia Global Summit, Madrid, Spain 22-24 September 2016.Integrated specialty service readiness in health reform: connections in haemophilia comprehensive care.Learning intravenous infusion in haemophilia: experience from the Netherlands.Patient- and caregiver-reported bleeding symptoms and reasons for starting and stopping treatment with recombinant factor VIIa: analysis of the Dosing Observational Study in Haemophilia (DOSE).E-learning improves knowledge and practical skills in haemophilia patients on home treatment: a randomized controlled trial.Guidelines for the management of hemophilia.'I don't want to hurt him.' Parents' experiences of learning to administer clotting factor to their child.
P2860
Q24234413-198DC38C-6D46-48C1-B37B-8510B2049D83Q24243897-D0763FC4-C846-4F45-8C48-B0EC937F881AQ30596332-B480F9ED-501D-4B19-AF49-255F993A61A7Q31098999-00BBC7D8-F282-4470-92F3-8A253211906BQ31115372-76127AC8-A4C2-485F-B3C2-8D41F8026DB0Q33937275-EFB11926-3611-41C7-ACDA-E92496BD01F3Q34060676-8F38112A-8C79-4331-9DF1-6DC58D1DA7C7Q34110064-D2D1F37A-E048-4AD7-B56E-8CDE0C106722Q34416394-4EB15AF6-C334-4366-AA5E-E835D6319B68Q35623619-895A579C-49CE-438C-B098-44AD432FDC8DQ36066048-30A7FE31-54E8-4C4C-8221-417DABD4B867Q36117533-06BC2874-3387-4C8E-B551-26F9976EEDCFQ36315174-2BE01FE7-87F6-41AD-A2A4-7352301C0A69Q36687522-45CB08C3-45AA-42D0-86F1-7A2462C1EE5CQ36863077-0B2F3F93-94C1-4E04-98FC-2E102EAC1400Q37015686-5A559F85-4C1B-4867-B3B7-7DFE26878ACBQ37052161-E463BBBC-A840-41BA-9958-85E5D4AEFD41Q38706471-D5BE93C3-5EBC-4063-8C3F-BED676931092Q38739036-7AC66A11-6425-4717-A5DB-7D83CB0E91B2Q39434363-0B6893A6-7B34-4B6F-9C0B-2C57F5DBA961Q39545557-536343FD-B6D6-4683-A3ED-009725EC149FQ40261649-A510686D-3FD0-47D0-82B9-E171A154A154Q40652826-78780105-856B-4A85-AB48-FBBE6169F31BQ42335907-060D8857-36BB-4929-9DFE-0803DC9AB5A5Q43577983-BF206C2C-E7E3-4E9A-A234-281CCC39731CQ43662496-5C402E2F-44E2-41BA-80E5-1C15D2CF605CQ44259168-8D1FD551-6446-4304-8AA0-E00DF9346D35Q44460074-DA8CCBC5-188E-4AA1-92DA-BA88CDA6589DQ44648378-B2E055D0-A6BF-4C61-9527-97BA0ADACBF8Q45861239-66C40D45-FC3C-47BE-8D15-01E9461D6959Q45864032-30C446DC-5CB2-4EB3-A537-28BB324269B8Q45865826-A7CF9D68-A73B-457F-94E7-9EE5E2DC143EQ45869051-23D5CEBB-CEC3-451D-A3E6-DBBD31DA043AQ45872095-6ADA406B-A4BF-452D-88C3-D2C29C330417Q45875827-BCE2C862-3906-4BC5-B511-6C869B1E9C4FQ45876745-2B6070E9-388D-43FB-BAE2-C816EFE1B5E9Q45877257-F528F823-5201-40F1-B014-62BA02C09B20Q45878205-B07B7534-0120-470B-8561-AA053BCA166AQ45880345-D64328C9-70BD-4323-B5F3-3CCAEDF9C463Q45882309-AFF6A081-6B2F-4750-9E8C-CAB73E05A006
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Home management of haemophilia.
@ast
Home management of haemophilia.
@en
type
label
Home management of haemophilia.
@ast
Home management of haemophilia.
@en
prefLabel
Home management of haemophilia.
@ast
Home management of haemophilia.
@en
P2093
P2860
P1433
P1476
Home management of haemophilia
@en
P2093
P2860
P304
P356
10.1046/J.1365-2516.2003.00853.X
P50
P577
2004-03-01T00:00:00Z